January 15, 2023
2 min watch
Save
VIDEO: Emerging treatments promising for wet AMD
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Carl D. Regillo, MD, discusses promising treatments for wet AMD, as well as phase 3 data from the Archway trial.
Regillo further discusses recent setbacks involving the port delivery system (Susvimo, Genentech) as well as recent accomplishments in the gene therapy space.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Regillo reports relevant financial disclosures with 4DMT, Adverum, Allergan Annexon, Apellis, Astellas, Clearside, EyePoint, Genentech, Graybug, Gyroscope, Iveric Bio, Janssen, Kodiak, Lineage Cell Therapeutics, Merck, NGM, Notal, Novartis, Ocugen, Opthea, Regeneron, Regenxbio, Stealth BioTherapeutics, Théa and Zeiss.
Read more about